Table 4.
Clinical efficacy of patients followed up after FMT [cases n (%)].
| Groups | Followed up for 1 months | Followed up for 3 months | Followed up for 6 months | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sum(n) | Clinical remission | Clinical improvement | Clinical invalid | Sum(n) | Clinical remission | Clinical improvement | Clinical invalid | Sum(n) | Clinical remission | Clinical improvement | Clinical invalid | |
| CDI | 7 | 6 (85.7) | 0 | 1 (14.3) | 7 | 6 (85.7) | 0 | 1 (14.3) | 7 | 5 (71.4) | 0 | 2 (28.6) |
| CID | 9 | 6 (66.6) | 0 | 3 (33.3) | 9 | 5 (55.5) | 2 (22.2) | 2 (22.2) | 8 | 3 (37.5) | 1 (12.5) | 4 (50.0) |
| FC | 18 | 12 (66.6) | 4 (22.2) | 2 (11.1) | 18 | 12 (66.6) | 3(16.6) | 3 (16.6) | 18 | 9(50.0) | 4 (22.2) | 5 (27.7) |
| UC | 12 | 8 (66.6) | 2 (16.6) | 2 (16.6) | 12 | 8 (66.6) | 1 (8.3) | 3 (25.0) | 12 | 6(50.0) | 2 (16.6) | 4 (33.3) |
| AD | 6 | 2 (33.3) | 3 (50.0) | 1 (16.7) | 6 | 3 (50.0) | 2 (33.3) | 1 (16.7) | 6 | 2 (33.3) | 1 (16.7) | 3 (50.0) |
| AC | 22 | 20 (90.9) | 0 | 2 (9.1) | 22 | 20 (90.9) | 0 | 2(9.1) | 20 | 16 (80.0) | 0 | 4 (20.0) |
CDI, C. difficile infection; AC, infantile allergic colitis; CID, chronic intractable diarrhea; UC, ulcerative colitis; AD, atopic dermatitis; FC, functional constipation.